1. Pain News Network: Widespread pain raises risk of dementia and stroke From the article: "While the number of cases was small, researchers found an association between pain and cognitive decline. Participants with widespread pain were 43% more likely to have some type of dementia, 47% more

1. ScienceAlert.com: Chronic pain has 9 distinct types, according to a large new body mapping study From the article: "Using a computer clustering analysis of patient body pain maps and pain assessments, the researchers discovered that patients fit into nine groups of chronic pain. ... What's

Note: It's been a slow week for fibromyalgia and Lyme news, so you'll notice #4 and #5 are older articles. I had saved both articles for my weekly news posts when they published, but just never got around to sharing them ... until now! 1. Pain News Network: Study of fibromyalgia drug continues

1. BusinessWire.com: Virios Therapeutics highlights clinical sites fully operational in phase 2b fibromyalgia study featuring FDA “fast track” review designated antiviral therapy, oral IMC-1 From the article: "Virios Therapeutics, Inc., a clinical-stage biotechnology company focused on

1. NeuroMetrix.com: NeuroMetrix receives FDA breakthrough device designation for treatment of fibromyalgia with its wearable neurostimulation technology From the article: "A total of 119 subjects with fibromyalgia were enrolled and randomized to a standard (active) or modified (sham) Quell

1. Pain News Network: Revised CDC opioid guideline not expected until late 2022 From the article: “CDC anticipates that the draft updated guideline will be posted for public comment by the end of 2021. This will provide another critical opportunity for diverse input from the public,” Lenard